ANDA 203950, held by Hospira. Oxacillin Sodium.
As of Nov 15, 2026, ANDA 203950 (Oxacillin Sodium), held by Hospira, was first approved by FDA on Dec 11, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 11, 2015 | Original application | Approved |
| Oxacillin SodiumEQ 1GM BASE/VIAL · injectable;injection | Oxacillin Sodium | Discontinued |
| Oxacillin SodiumEQ 2GM BASE/VIAL · injectable;injection | Oxacillin Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
